
  
    
      
        Background_NNP
        Recent_JJ U_NNP ._. S_NNP ._. national_JJ surveys_NNS [_NN 1_CD ]_NN show_NN that_IN in_IN 1999_CD ,_,
        18_CD ._. 9_CD %_NN of_IN Americans_NNPS were_VBD frankly_RB obese_NN ,_, a_DT marked_VBN increase_NN
        from_IN 17_CD ._. 8_CD %_NN in_IN 1998_CD ,_, underscoring_VBG the_DT fact_NN that_IN over_IN the_DT
        last_JJ few_JJ decades_NNS ,_, an_DT emerging_VBG epidemic_NN of_IN obesity_NN has_VBZ
        become_VBN a_DT major_JJ cause_NN of_IN preventable_JJ death_NN [_NN 2_CD ]_NN and_CC disease_NN
        [_NN 3_CD ]_NN ._. Recognizing_NNP the_DT effects_NNS of_IN obesity_NN on_IN the_DT nation_NN 's_POS
        health_NN ,_, governments_NNS and_CC industry_NN have_VBP vigorously_RB pursued_VBN
        the_DT genetic_JJ ,_, metabolic_JJ and_CC environmental_JJ roots_NNS of_IN obesity_NN [_NN
        4_CD 5_CD 6_CD 7_CD ]_NN ._. Despite_IN the_DT effort_NN ,_, it_PRP remains_VBZ true_JJ that_IN little_JJ
        is_VBZ known_VBN about_IN prevention_NN of_IN obesity_NN and_CC its_PRP$ treatment_NN
        remains_VBZ no_DT less_RBR difficult_JJ or_CC failure_NN prone_JJ than_IN it_PRP ever_RB was_VBD
        [_NN 8_CD 9_CD 10_CD ]_NN ._.
        Attention_NN Deficit_NNP /_NN Hyperactivity_NNP Disorder_NNP (_( ADHD_NNP )_) is_VBZ also_RB
        a_DT common_JJ disorder_NN ,_, even_RB if_IN its_PRP$ prevalence_NN is_VBZ not_RB precisely_RB
        known_VBN ._. In_IN children_NNS ,_, the_DT rate_NN of_IN occurrence_NN has_VBZ customarily_RB
        been_VBN given_VBN as_IN 3_CD to_TO 5_CD %_NN ,_, but_CC recent_JJ studies_NNS show_VBP the_DT
        condition_NN is_VBZ present_JJ in_IN 15_CD %_NN or_CC more_JJR of_IN school_NN age_NN
        populations_NNS [_NN 11_CD 12_CD ]_NN ._. Persistence_NNP of_IN ADHD_NNP into_IN adulthood_NN
        has_VBZ been_VBN shown_VBN to_TO occur_VB in_IN 30_CD to_TO 50_CD %_NN (_( or_CC more_JJR )_) of_IN childhood_NN
        cases_NNS [_NN 13_CD ]_NN ,_, depending_VBG on_IN the_DT criteria_NNS used_VBD [_NN 14_CD ]_NN ._. It_PRP
        is_VBZ clear_JJ that_IN adults_NNS with_IN a_DT history_NN of_IN ADHD_NNP in_IN childhood_NN
        have_VBP greater_JJR difficulty_NN functioning_VBG compared_VBN to_TO their_PRP$
        non-_NN ADHD_NNP peers_NNS [_NN 15_CD ]_NN ._. One_CD example_NN is_VBZ the_DT higher_JJR rate_NN of_IN
        substance_NN use_NN disorders_NNS in_IN ADHD_NNP adults_NNS compared_VBN to_TO the_DT
        general_JJ population_NN [_NN 16_CD ]_NN ,_, such_JJ use_NN often_RB viewed_VBD as_IN a_DT kind_NN
        of_IN "_'' self-medication_JJ "_'' of_IN unpleasant_JJ emotions_NNS [_NN 16_CD ]_NN ._. In_IN
        obesity_NN ,_, similar_JJ patterns_NNS of_IN eating_VBG (_( seeking_VBG immediate_JJ
        gratification_NN ,_, using_VBG food_NN to_TO reduce_VB dysphoria_NN )_) have_VBP been_VBN
        observed_VBN [_NN 17_CD ]_NN ,_, though_IN not_RB previously_RB linked_VBN to_TO ADHD_NNP ._.
        It_PRP is_VBZ established_VBN that_DT obesity_NN has_VBZ serious_JJ medical_JJ
        sequelae_NN ,_, and_CC that_IN both_DT obesity_NN and_CC ADHD_NNP have_VBP psychiatric_JJ
        comorbidities_NNS [_NN 18_CD 19_CD 20_CD 21_CD 22_CD 23_CD ]_NN ,_, but_CC surprisingly_RB ,_,
        searches_NNS found_VBD no_DT existing_VBG literature_NN describing_VBG comorbid_NN
        obesity_NN and_CC ADHD_NNP (_( OB_NNP +_NN ADHD_NNP )_) ._. However_RB ,_, one_CD study_NN [_NN 24_CD ]_NN
        reported_VBD a_DT potentially_RB relevant_JJ correlation_NN between_IN
        symptoms_NNS of_IN conduct_NN disorder_NN (_( but_CC not_RB depression_NN )_) during_IN
        adolescence_NN and_CC obesity_NN in_IN early_JJ adulthood_NN ,_, attributed_VBD to_TO
        common_JJ mechanisms_NNS underlying_VBG "_'' impulsive_JJ aggression_NN "_'' and_CC
        dysregulation_NN of_IN body_NN weight_NN ._. The_DT role_NN of_IN impulsivity_NN in_IN
        this_DT correlation_NN is_VBZ important_JJ ,_, given_VBN that_IN impulsive_JJ
        behavior_NN is_VBZ common_JJ in_IN adolescents_NNS with_IN ADHD_NNP ,_, pointing_VBG to_TO a_DT
        connection_NN between_IN ADHD_NNP and_CC development_NN of_IN obesity_NN ,_, an_DT idea_NN
        consistent_JJ with_IN our_PRP$ clinical_JJ observation_NN that_IN impulsive_JJ
        eating_NN behaviors_NNS are_VBP common_JJ in_IN adult_NN and_CC adolescent_JJ OB_NNP +_NN ADHD_NNP
        patients_NNS ._.
        With_IN persistent_JJ effort_NN some_DT bariatric_JJ patients_NNS have_VBP been_VBN
        able_JJ to_TO achieve_VB and_CC maintain_VB a_DT reduced_VBN level_NN of_IN body_NN fat_JJ ._.
        In_IN the_DT bariatric_JJ clinic_NN at_IN Behavioral_NNP Medicine_NNP Center_NNP for_IN
        Treatment_NNP and_CC Research_NNP (_( BMedCTR_NNP )_) in_IN Portland_NNP ,_, Oregon_NNP ,_, among_IN
        the_DT patients_NNS who_WP failed_VBD ,_, a_DT subset_NN was_VBD observed_VBN to_TO have_VB
        unusual_JJ difficulty_NN adhering_VBG to_TO diet_NN and_CC exercise_NN plans_NNS ,_, and_CC
        as_IN a_DT result_NN lost_VBD less_RBR fat_JJ mass_NN than_IN typically_RB occurs_VBZ ._.
        Diagnostic_NNP evaluation_NN showed_VBD a_DT substantial_JJ fraction_NN of_IN
        these_DT patients_NNS had_VBD Attention_NN Deficit_NNP /_NN Hyperactivity_NNP Disorder_NNP
        (_( ADHD_NNP )_) ,_, a_DT condition_NN that_WDT was_VBD recognized_VBN in_IN our_PRP$ clinical_JJ
        work_NN as_IN a_DT risk_NN factor_NN for_IN poor_JJ treatment_NN outcome_NN ._.
        Fortunately_RB ,_, ADHD_NNP patients_NNS often_RB responded_VBD to_TO
        pharmacological_JJ and_CC behavior_NN therapies_NNS ,_, with_IN results_NNS that_WDT
        included_VBD improved_VBN task_NN persistence_NN ,_, decreased_VBD impulsivity_NN
        and_CC distractability_NN ,_, and_CC for_IN some_DT ,_, greater_JJR success_NN with_IN
        weight_NN control_NN efforts_NNS ._.
        Cumulative_NNP bariatric_JJ clinic_NN experience_NN showed_VBD OB_NNP +_NN ADHD_NNP
        was_VBD commonly_RB encountered_VBN ,_, and_CC a_DT potent_JJ contributor_NN to_TO
        obesity_NN treatment_NN failure_NN ._. In_IN this_DT context_NN it_PRP became_VBD clear_JJ
        that_IN more_JJR information_NN about_IN OB_NNP +_NN ADHD_NNP was_VBD needed_VBN and_CC that_IN
        wider_JJR exposure_NN of_IN this_DT comorbidity_NN would_MD be_VB valuable_JJ (_( and_CC
        interesting_JJ )_) to_TO clinicians_NNS treating_VBG obese_NN patients_NNS ._.
        Consequently_RB ,_, this_DT report_NN was_VBD constructed_VBN to_TO begin_VB
        exploring_VBG the_DT basic_JJ characteristics_NNS of_IN this_DT heretofore_RB
        unrecognized_JJ population_NN ._.
      
      
        Methods_NNP
        The_DT primary_JJ working_NN hypothesis_NNS was_VBD that_IN the_DT prevalence_NN
        of_IN ADHD_NNP among_IN obese_NN patients_NNS was_VBD higher_JJR than_IN in_IN the_DT general_JJ
        adult_NN population_NN ._. In_IN addition_NN ,_, it_PRP was_VBD anticipated_VBN that_IN ADHD_NNP
        patients_NNS would_MD have_VB less_JJR weight_NN loss_NN ,_, fewer_JJR visits_NNS and_CC
        shorter_JJR duration_NN of_IN treatment_NN than_IN their_PRP$ non-_NN ADHD_NNP peers_NNS ._.
        Differences_NNS between_IN groups_NNS were_VBD not_RB expected_VBN to_TO be_VB widely_RB
        divergent_JJ ._.
        The_DT method_NN used_VBN to_TO conduct_VB a_DT systematic_JJ examination_NN of_IN
        clinical_JJ data_NNS was_VBD a_DT retrospective_NN review_NN of_IN medical_JJ records_NNS
        of_IN patients_NNS who_WP had_VBD been_VBN treated_VBN for_IN obesity_NN at_IN BMedCTR_NNP
        during_IN the_DT period_NN ,_, Jan_NNP 1_CD ,_, 2000_CD through_IN Dec_NNP 31_CD ,_, 2000_CD ,_, and_CC
        enrolled_VBD in_IN treatment_NN by_IN Nov_NNP 30_CD ,_, 2000_CD ._. The_DT clinic_NN 's_POS
        scheduling_NN database_NN referenced_JJ 215_CD unique_JJ individuals_NNS who_WP
        were_VBD active_JJ patients_NNS during_IN the_DT study_NN period_NN ._.
        Data_NNP relevant_JJ to_TO demographic_JJ and_CC clinical_JJ status_NN was_VBD
        collected_VBN from_IN medical_JJ records_NNS including_VBG age_NN ,_, sex_NN ,_, body_NN
        mass_NN index_NN (_( BMI_NNP )_) at_IN first_JJ and_CC last_JJ visits_NNS ,_, interval_NN between_IN
        first_JJ and_CC last_JJ visits_NNS ,_, number_NN of_IN visits_NNS ,_, and_CC diagnosis_NN of_IN
        ADHD_NNP entered_VBD in_IN the_DT record_NN during_IN the_DT course_NN of_IN obesity_NN
        treatment_NN ._. This_DT diagnosis_NN was_VBD not_RB determined_VBN
        retrospectively_RB ,_, although_IN the_DT diagnosis_NN was_VBD confirmed_VBN to_TO be_VB
        supported_VBN by_IN the_DT written_VBN record_NN of_IN behavioral_JJ observations_NNS ._.
        The_DT 215_CD records_NNS were_VBD were_VBD divided_VBN into_IN 3_CD groups_NNS :_: patients_NNS
        without_IN ADHD_NNP (_( NAD_NNP )_) ,_, those_DT with_IN ADHD_NNP symptoms_NNS or_CC behaviors_NNS ,_,
        but_CC not_RB meeting_VBG diagnostic_JJ criteria_NNS for_IN ADHD_NNP (_( ADSx_NNP )_) ,_, and_CC
        patients_NNS with_IN ADHD_NNP (_( AD_NNP )_) ._.
        Diagnosis_NNP of_IN ADHD_NNP was_VBD made_VBN by_IN the_DT author_NN during_IN the_DT
        course_NN of_IN patients_NNS '_POS obesity_NN treatment_NN ,_, using_VBG
        semi-structured_JJ interviews_NNS over_IN one_CD or_CC more_JJR visits_NNS ._.
        Structure_NNP was_VBD in_IN accord_NN with_IN DSM-IV_NNP criteria_NNS ,_, that_WDT is_VBZ ,_, a_DT
        patient_NN needed_VBN to_TO have_VB shown_VBN ,_, or_CC given_VBN substantial_JJ history_NN
        of_IN 6_CD or_CC more_RBR inattentive_JJ behaviors_NNS to_TO be_VB considered_VBN as_IN
        having_VBG ADHD_NNP ._. Patients_NNS who_WP had_VBD fewer_JJR than_IN 6_CD ,_, but_CC at_IN least_JJS 3_CD
        inattentive_JJ symptoms_NNS were_VBD classified_VBN as_IN having_VBG symptoms_NNS of_IN
        ADHD_NNP but_CC not_RB diagnosed_VBN as_IN having_VBG the_DT disorder_NN ._. None_NN of_IN the_DT
        patients_NNS had_VBD as_RB many_JJ as_IN 6_CD hyperactive-impulsive_JJ symptoms_NNS ._.
        (_( Patients_NNPS '_POS inattentive_JJ and_CC hyperactive_JJ /_NN impulsive_JJ behaviors_NNS
        were_VBD not_RB separately_RB tabulated_JJ during_IN records_NNS review_VBP ._. )_) At_IN
        the_DT time_NN diagnoses_NNS had_VBD been_VBN made_VBN ,_, a_DT behavior_NN was_VBD not_RB
        considered_VBN a_DT symptom_NN of_IN ADHD_NNP if_IN occurring_VBG only_RB in_IN
        association_NN with_IN obesity_NN treatment_NN ,_, for_IN example_NN ,_, trouble_NN
        adhering_VBG to_TO diet_NN or_CC exercise_NN plans_NNS ._. A_DT significant_JJ level_NN of_IN
        impairment_NN associated_VBN with_IN symptoms_NNS was_VBD required_VBN for_IN ADHD_NNP
        to_TO be_VB diagnosed_VBN ._. While_IN many_JJ of_IN the_DT patients_NNS had_VBD current_JJ or_CC
        past_JJ treatment_NN for_IN depression_NN or_CC anxiety_NN ,_, these_DT conditions_NNS
        were_VBD required_VBN to_TO be_VB in_IN remission_NN or_CC insufficiently_RB
        prominent_JJ to_TO obscure_VB or_CC account_NN for_IN ADHD_NNP behavior_NN or_CC
        impairment_NN for_IN the_DT diagnosis_NN of_IN ADHD_NNP to_TO be_VB made_VBN ._.
        The_DT interview_NN method_NN is_VBZ termed_VBN semi-structured_JJ because_IN
        in_IN a_DT clinical_JJ setting_NN the_DT approach_NN to_TO each_DT patient_NN was_VBD
        necessarily_RB individualized_JJ (_( at_IN least_JJS to_TO some_DT degree_NN )_) ._.
        Within_IN this_DT constraint_NN ,_, information_NN was_VBD gathered_VBN in_IN a_DT
        reasonably_RB consistent_JJ manner_NN ,_, in_IN that_IN the_DT same_JJ pieces_NNS of_IN
        information_NN were_VBD sought_VBN from_IN each_DT patient_NN ,_, the_DT same_JJ
        questions_NNS asked_VBD of_IN each_DT ,_, even_RB if_IN the_DT order_NN of_IN inquiry_NN
        varied_VBD ,_, that_WDT is_VBZ to_TO say_VB ,_, the_DT path_NN through_IN the_DT "_'' decision_NN
        tree_NN "_'' reflected_VBD patients_NNS '_POS differences_NNS ._.
        During_IN the_DT period_NN of_IN treatment_NN ,_, and_CC diagnosis_NN ,_, a_DT single_JJ
        exception_NN to_TO DSM-IV_NNP ADHD_NNP diagnostic_JJ criteria_NNS was_VBD made_VBN
        regarding_VBG age_NN of_IN onset_NN (_( nominally_RB 7_CD years_NNS )_) ,_, for_IN several_JJ
        reasons_NNS ._. Pragmatically_NNP ,_, adult_NN patients_NNS were_VBD often_RB uncertain_JJ
        about_IN the_DT precise_JJ age_NN symptoms_NNS began_VBD ,_, though_IN often_RB able_JJ to_TO
        identify_VB a_DT time_NN in_IN early_JJ childhood_NN when_WRB symptoms_NNS were_VBD
        already_RB occurring_VBG ,_, e_SYM ._. g_SYM ._. ,_, "_'' in_IN the_DT 2_CD nd_NN or_CC 3_CD rd_NN grade_NN "_'' ,_, making_VBG
        it_PRP impossible_JJ to_TO be_VB certain_JJ if_IN symptoms_NNS were_VBD present_JJ before_IN
        age_NN 7_CD ._. For_IN middle-aged_JJ adults_NNS ,_, third_JJ party_NN confirmation_NN of_IN
        early_JJ events_NNS was_VBD seldom_RB available_JJ ,_, leaving_VBG the_DT patient_NN 's_POS
        recall_NN as_IN the_DT only_JJ data_NN source_NN ._. Recent_JJ studies_NNS have_VBP shown_VBN
        that_DT patient_NN memory_NN was_VBD consistent_JJ enough_RB with_IN other_JJ
        information_NN to_TO be_VB useful_JJ for_IN diagnostic_JJ purposes_NNS [_NN 25_CD ]_NN ._.
        Patients_NNPS '_POS reports_NNS were_VBD likely_JJ to_TO be_VB accurate_JJ ,_, but_CC there_EX
        were_VBD often_RB "_'' gaps_NNS "_'' in_IN memory_NN of_IN early_JJ experience_NN ,_, not_RB
        inconsistent_JJ with_IN ADHD_NNP in_IN general_JJ ,_, favoring_VBG an_DT inference_NN
        that_IN they_PRP did_VBD n't_RB remember_VB their_PRP$ behavior_NN rather_RB than_IN not_RB
        having_VBG had_VBN the_DT behavior_NN ._. It_PRP was_VBD concluded_VBN that_IN the_DT risk_NN of_IN
        misdiagnosis_NNS by_IN modifying_VBG the_DT age_NN of_IN onset_NN criterion_NN was_VBD
        much_RB lower_JJR than_IN the_DT risks_NNS of_IN not_RB diagnosing_VBG a_DT condition_NN for_IN
        which_WDT treatment_NN can_MD make_VB a_DT great_JJ difference_NN in_IN life_NN
        quality_NN ._. In_IN other_JJ words_NNS ,_, for_IN this_DT population_NN the_DT risks_NNS of_IN
        underdiagnosing_VBG ADHD_NNP were_VBD judged_VBN to_TO be_VB far_RB more_JJR
        consequential_NN than_IN risks_NNS of_IN overdiagnosing_VBG the_DT disorder_NN ._.
        Accordingly_RB ,_, during_IN treatment_NN ,_, diagnosis_NN of_IN ADHD_NNP was_VBD made_VBN
        when_WRB all_DT other_JJ DSM-IV_NNP criteria_NNS were_VBD met_VBN and_CC symptoms_NNS were_VBD
        clearly_RB evident_JJ by_IN 12_CD years_NNS of_IN age_NN ._.
        A_DT similar_JJ point_NN was_VBD made_VBN by_IN Wender_NNP [_NN 26_CD ]_NN ,_, who_WP argued_VBD
        that_DT availability_NN of_IN low-risk_JJ treatments_NNS for_IN debilitating_JJ
        conditions_NNS warrants_NNS clinicians_NNS using_VBG less_RBR specific_JJ criteria_NNS
        to_TO avoid_VB excluding_VBG patients_NNS who_WP may_MD benefit_VB ._. A_DT different_JJ
        argument_NN was_VBD made_VBN by_IN Barkley_NNP and_CC Biederman_NNP [_NN 27_CD ]_NN ,_, that_IN
        requiring_VBG symptoms_NNS to_TO have_VB been_VBN present_JJ by_IN a_DT single_JJ ,_,
        specific_JJ point_NN in_IN early_JJ childhood_NN in_IN order_NN to_TO diagnose_NN ADHD_NNP
        is_VBZ not_RB rational_JJ ,_, that_WDT is_VBZ ,_, ADHD_NNP is_VBZ better_RBR conceptualized_JJ as_IN
        a_DT disorder_NN arising_VBG in_IN childhood_NN generally_RB ._.
        None_NN of_IN the_DT ADHD_NNP group_NN had_VBD a_DT level_NN of_IN
        hyperactivity-impulsivity_JJ meeting_NN DSM-IV_NNP criteria_NNS ,_,
        therefore_RB all_DT were_VBD classifiable_JJ as_IN having_VBG Inattentive_NNP Type_NNP
        of_IN ADHD_NNP ._.
        Data_NNP were_VBD tested_VBN using_VBG Unix-based_NNP tools_NNS including_VBG xmstat_NN
        and_CC xlispstat_NN ._. Significance_NN was_VBD set_VBN at_IN α_NN =_SYM 0_CD ._. 05_CD ._. Analysis_NNP
        of_IN variance_NN was_VBD applied_VBN to_TO means_NNS of_IN age_NN ,_, starting_VBG BMI_NNP ,_,
        difference_NN between_IN starting_VBG and_CC ending_VBG BMI_NNP ,_, number_NN of_IN
        visits_NNS and_CC length_NN of_IN treatment_NN ._. Chi-square_NNP test_NN was_VBD used_VBN to_TO
        determine_VB significance_NN of_IN differences_NNS among_IN patient_NN groups_NNS
        and_CC BMI_NNP categories_NNS ._. NIH_NNP classification_NN [_NN 3_CD ]_NN of_IN BMI_NNP was_VBD
        used_VBN ,_, defining_VBG Obesity_NNP III_NNP (_( Extreme_NNP Obesity_NNP )_) as_IN BMI_NNP >_NN =_SYM
        40_CD ,_, Obesity_NNP classes_NNS I_PRP and_CC II_NNP (_( Obesity_NNP )_) as_IN BMI_NNP 30_CD to_TO 39_CD ._. 9_CD ,_,
        and_CC Overweight_NNP as_IN BMI_NNP 25_CD to_TO 29_CD ._. 9_CD ._.
      
      
        Results_NNS
        Results_NNS are_VBP summarized_VBD in_IN Table_NNP 1_CD ._. While_IN the_DT patients_NNS in_IN
        the_DT sample_NN were_VBD predominantly_RB female_JJ ,_, there_EX was_VBD no_DT
        significant_JJ difference_NN in_IN age_NN (_( F_NN =_SYM 0_CD ._. 52_CD ,_, df_NN =_SYM 2_CD ,_, 212_CD ,_, p_NN =_SYM
        NS_NNP )_) or_CC gender_NN distribution_NN (_( chi-square_JJ =_SYM 2_CD ._. 35_CD ,_, df_NN =_SYM 2_CD ,_, p_NN =_SYM
        0_CD ._. 31_CD )_) among_IN patient_NN groups_NNS ._. Mean_VB Starting_VBG BMI_NNP -_: Ending_VBG BMI_NNP
        was_VBD 3_CD ._. 32_CD for_IN males_NNS ,_, 3_CD ._. 02_CD for_IN females_NNS ,_, but_CC the_DT difference_NN
        was_VBD not_RB significant_JJ (_( unpaired_JJ t-test_JJ ,_, t_NN =_SYM 1_CD ._. 73_CD ,_, df_NN =_SYM 21_CD ,_,
        192_CD ,_, 213_CD ,_, p_NN =_SYM 0_CD ._. 09_CD )_) ._.
        Subjects_NNP were_VBD characterized_VBN by_IN a_DT variable_JJ level_NN of_IN
        obesity_NN ,_, divided_VBN into_IN one_CD of_IN three_CD obesity_NN classes_NNS
        (_( overweight_NN :_: Ov_NNP ,_, moderate_JJ to_TO severe_JJ obesity_NN :_: I-II_NNP ,_, and_CC
        extreme_JJ obesity_NN :_: III_NNP )_) ,_, and_CC a_DT range_NN of_IN symptoms_NNS (_( AD_NNP ,_, ADSx_NNP ,_, or_CC
        NAD_NNP )_) ._. These_DT classifications_NNS were_VBD organized_VBN into_IN a_DT 3_CD ×_NN 3_CD
        array_NN which_WDT was_VBD suitable_JJ for_IN determining_VBG prevalence_NN of_IN ADHD_NNP
        in_IN whole_JJ sample_NN and_CC looking_VBG at_IN the_DT differences_NNS in_IN ADHD_NNP
        prevalence_NN among_IN the_DT classes_NNS of_IN obesity_NN ._.
        The_DT whole_JJ sample_NN of_IN 215_CD obese_NN patients_NNS ,_, partitioned_JJ by_IN
        ADHD_NNP group_NN ,_, contains_VBZ 59_CD ,_, or_CC 27_CD ._. 4_LS %_NN (_( 95_CD %_NN CI_NNP :_: 21_CD ._. 1_LS %_NN to_TO 32_CD ._. 9_CD %_NN )_)
        with_IN AD_NNP ,_, 72_CD or_CC 33_CD ._. 5_LS %_NN (_( CI_NNP :_: 27_CD ._. 2_LS %_NN to_TO 39_CD ._. 8_CD %_NN )_) were_VBD ADSx_NNP ,_, and_CC 84_CD
        or_CC 39_CD ._. 1_LS %_NN (_( CI_NNP :_: 32_CD ._. 6_CD %_NN to_TO 45_CD ._. 6_CD %_NN )_) were_VBD NAD_NNP ._. Chi-square_NNP test_NN of_IN
        patient_NN groups_NNS (_( AD_NNP ,_, ADSx_NNP ,_, NAD_NNP )_) vs_NNS ._. obesity_NN classes_NNS (_( III_NNP ,_,
        I-II_NNP ,_, Ov_NNP )_) showed_VBD that_IN differences_NNS in_IN the_DT 3_CD ×_NN 3_CD table_NN were_VBD
        significant_JJ (_( chi-square_JJ =_SYM 11_CD ._. 23_CD ,_, df_NN =_SYM 4_CD ,_, p_NN <_NN 0_CD ._. 025_CD )_) ._. The_DT
        proportion_NN of_IN patients_NNS having_VBG ADHD_NNP in_IN obesity_NN class_NN III_NNP
        (_( Ob-_NNP III_NNP )_) was_VBD significantly_RB greater_JJR than_IN for_IN Obesity_NNP I-II_NNP
        (_( Ob-_NNP I_PRP /_NN II_NNP )_) and_CC Ov_NNP (_( chi-square_JJ =_SYM 9_CD ._. 86_CD ,_, df_NN =_SYM 1_CD ,_, p_NN =_SYM 0_CD ._. 002_CD )_) ._.
        However_RB ,_, the_DT proportion_NN of_IN AD_NNP in_IN the_DT Ov_NNP class_NN did_VBD not_RB
        significantly_RB differ_VB from_IN Ob-_NNP I_PRP /_NN II_NNP and_CC Ob-_NNP III_NNP (_( chi-square_JJ =_SYM
        2_CD ._. 60_CD ,_, df_NN =_SYM 1_CD ,_, p_NN =_SYM 0_CD ._. 11_CD )_) ._.
        There_EX were_VBD 26_CD patients_NNS with_IN ADHD_NNP and_CC Ob-_NNP III_NNP ,_, which_WDT is_VBZ
        42_CD ._. 6_CD %_NN (_( CI_NNP :_: 36_CD ._. 3_LS %_NN to_TO 48_CD ._. 9_CD %_NN )_) of_IN all_DT 61_CD Ob-_NNP III_NNP patients_NNS in_IN the_DT
        sample_NN ._. Similarly_RB ,_, there_EX were_VBD 23_CD AD_NNP with_IN Ob-_NNP I_PRP /_NN II_NNP (_( 22_CD ._. 8_CD %_NN
        [_NN CI_NNP :_: 14_CD ._. 6_CD %_NN to_TO 31_CD ._. 0_CD %_NN ]_NN of_IN 101_CD Ob-_NNP I_PRP /_NN II_NNP )_) ,_, and_CC 10_CD AD_NNP in_IN Ov_NNP (_( 18_CD ._. 9_CD %_NN
        [_NN CI_NNP :_: 8_CD ._. 4_LS %_NN to_TO 29_CD ._. 4_LS %_NN ]_NN of_IN 53_CD Ov_NNP )_) ,_, though_IN the_DT value_NN for_IN AD_NNP /_NN Ov_NNP
        was_VBD not_RB statistically_RB distinct_JJ from_IN AD_NNP in_IN other_JJ obesity_NN
        classes_NNS ._.
        Analysis_NNP of_IN variance_NN of_IN patients_NNS '_POS BMI_NNP at_IN the_DT start_NN of_IN
        treatment_NN showed_VBD a_DT significant_JJ difference_NN among_IN the_DT group_NN
        means_VBZ (_( F_NN =_SYM 5_CD ._. 86_CD ,_, df_NN =_SYM 2_CD ,_, 212_CD ,_, p_NN =_SYM 0_CD ._. 003_CD )_) ,_, with_IN AD_NNP having_VBG a_DT
        higher_JJR BMI_NNP (_( 39_CD ._. 2_LS )_) than_IN ADSx_NNP (_( 35_CD ._. 5_LS )_) and_CC NAD_NNP (_( 34_CD ._. 6_CD )_) ._. Further_RB
        analysis_NN with_IN the_DT Fisher_NNP multiple_JJ comparison_NN test_NN found_VBD AD_NNP
        differed_VBD from_IN ADSx_NNP and_CC NAD_NNP ,_, but_CC ADSx_NNP and_CC NAD_NNP were_VBD not_RB
        significantly_RB different_JJ (_( Fisher_NNP ,_, AD-ADSx_NNP :_: p_NN =_SYM 0_CD ._. 001_CD ,_,
        AD-NAD_NNP :_: p_NN =_SYM 0_CD ._. 01_CD ,_, ADSx-NAD_NNP :_: p_NN =_SYM 0_CD ._. 49_CD )_) ._.
        Body_NN weight_NN loss_NN was_VBD calculated_VBN as_IN Starting_VBG BMI_NNP -_: Ending_VBG
        BMI_NNP ._. NAD_NNP achieved_VBD nearly_RB twice_RB the_DT BMI_NNP loss_NN as_IN AD_NNP and_CC ADSx_NNP ,_,
        at_IN means_NNS of_IN 4_CD ._. 0_CD ,_, 2_CD ._. 6_CD and_CC 2_CD ._. 3_CD respectively_RB (_( F_NN =_SYM 6_CD ._. 25_CD ,_, df_NN =_SYM
        2_CD ,_, 212_CD ,_, p_NN =_SYM 0_CD ._. 002_CD )_) ._. NAD_NNP was_VBD distinct_JJ from_IN AD_NNP and_CC ADSx_NNP
        (_( Fisher_NNP ,_, NAD-AD_NNP :_: p_NN <_NN 0_CD ._. 009_CD ,_, NAD-ADSx_NNP :_: p_NN <_NN ._. 001_CD ,_,
        AD-ADSx_NNP :_: p_NN =_SYM 0_CD ._. 666_CD )_) ._. As_IN percent_NN change_NN from_IN Starting_VBG BMI_NNP ,_,
        mean_VB loss_NN was_VBD 11_CD ._. 2_LS %_NN ,_, 6_CD ._. 5_CD %_NN and_CC 6_CD ._. 3_CD %_NN respectively_RB (_( F_NN =_SYM 8_CD ._. 40_CD ,_,
        df_NN =_SYM 2_CD ,_, 212_CD ,_, p_NN =_SYM <_NN 0_CD ._. 01_CD )_) ,_, with_IN NAD_NNP being_VBG significantly_RB
        different_JJ from_IN AD_NNP and_CC ADSx_NNP which_WDT did_VBD not_RB differ_VB from_IN each_DT
        other_JJ (_( Fisher_NNP ,_, NAD-AD_NNP :_: p_NN <_NN 0_CD ._. 001_CD ,_, NAD-ADSx_NNP :_: p_NN <_NN ._. 001_CD ,_,
        AD-ADSx_NNP :_: p_NN =_SYM 0_CD ._. 93_CD )_) ._.
        The_DT subgroup_NN of_IN patients_NNS having_VBG Obesity_NNP III_NNP showed_VBD a_DT
        larger_JJR difference_NN in_IN mean_NN BMI_NNP change_NN ,_, that_WDT is_VBZ ,_, BMI_NNP loss_NN by_IN
        ADHD_NNP status_NN for_IN members_NNS of_IN this_DT subgroup_NN was_VBD :_: NAD_NNP 7_CD ._. 0_CD (_( SD_NNP
        4_CD ._. 0_CD )_) ,_, AD_NNP 2_CD ._. 9_CD (_( SD_NNP 4_CD ._. 5_LS )_) and_CC ADSx_NNP 3_CD ._. 4_CD (_( SD_NNP 2_CD ._. 8_CD )_) (_( F_NN =_SYM 6_CD ._. 09_CD ,_, df_NN =_SYM
        2_CD ,_, 58_CD ,_, p_NN =_SYM 0_CD ._. 004_CD )_) ._. The_DT weight_NN loss_NN for_IN NAD_NNP was_VBD again_RB
        different_JJ from_IN Obesity_NNP III_NNP patients_NNS who_WP were_VBD AD_NNP or_CC ADSx_NNP ,_,
        but_CC AD_NNP and_CC ADSx_NNP were_VBD not_RB significantly_RB different_JJ (_( Fisher_NNP ,_,
        NAD-AD_NNP :_: p_NN <_NN 0_CD ._. 001_CD ,_, NAD-ADSx_NNP :_: p_NN <_NN 0_CD ._. 01_CD ,_, AD-ADSx_NNP :_: p_NN
        <_NN 0_CD ._. 657_CD )_) ._. The_DT Obesity_NNP III_NNP AD_NNP and_CC NAD_NNP were_VBD analyzed_VBN by_IN
        the_DT non-parametric_JJ approximate_JJ randomization_NN test_NN (_( AR_NNP test_NN )_)
        which_WDT also_RB showed_VBD a_DT significant_JJ difference_NN between_IN the_DT two_CD
        groups_NNS (_( p_NN =_SYM 0_CD ._. 003_CD (_( CI_NNP :_: 0_CD ._. 0019_CD to_TO 0_CD ._. 0041_CD )_) ,_, 10000_CD
        randomizations_NNS )_) ._.
        Among_IN the_DT whole_JJ sample_NN of_IN obese_NN patients_NNS ,_, mean_VB number_NN of_IN
        visits_NNS was_VBD greater_JJR in_IN AD_NNP (_( F_NN =_SYM 3_CD ._. 69_CD ,_, df_NN =_SYM 2_CD ,_, 212_CD ,_, p_NN =_SYM 0_CD ._. 027_CD )_)
        with_IN AD_NNP differing_VBG significantly_RB from_IN NAD_NNP and_CC ADSx_NNP (_( Fisher_NNP ,_,
        AD-NAD_NNP :_: p_NN =_SYM 0_CD ._. 02_CD ,_, AD-ADSx_NNP :_: p_NN =_SYM 0_CD ._. 01_CD ,_, NAD-ADSx_NNP :_: p_NN =_SYM 0_CD ._. 73_CD )_) ._.
        AR_NNP test_NN applied_VBN to_TO the_DT number_NN of_IN visits_NNS of_IN AD_NNP and_CC NAD_NNP
        revealed_VBD a_DT marginally_RB significant_JJ difference_NN (_( p_NN =_SYM 0_CD ._. 040_CD
        (_( CI_NNP :_: 0_CD ._. 036_CD to_TO 0_CD ._. 048_CD )_) ,_, 4000_CD randomizations_NNS )_) ._. The_DT number_NN of_IN
        months_NNS in_IN treatment_NN was_VBD not_RB significantly_RB different_JJ among_IN
        the_DT patient_NN groups_NNS (_( F_NN =_SYM 2_CD ._. 03_CD ,_, df_NN =_SYM 2_CD ,_, 212_CD ,_, p_NN =_SYM 0_CD ._. 13_CD )_) ,_, though_IN
        there_EX appeared_VBD to_TO be_VB a_DT trend_NN toward_IN alonger_NN duration_NN of_IN
        treatment_NN in_IN AD_NNP ._. AR_NNP test_NN results_NNS for_IN AD_NNP vs_NNS ._. NAD_NNP showed_VBD a_DT
        nearly_RB significant_JJ difference_NN ,_, remaining_VBG better_JJR described_VBD
        as_IN trend_NN toward_IN a_DT difference_NN (_( p_NN =_SYM 0_CD ._. 054_CD (_( CI_NNP :_: 0_CD ._. 050_CD to_TO
        0_CD ._. 058_CD )_) ,_, 12000_CD randomizations_NNS )_) ._.
      
      
        Discussion_NNP
        The_DT most_RBS important_JJ results_NNS are_VBP the_DT prevalence_NN of_IN ADHD_NNP of_IN
        27_CD ._. 4_LS %_NN in_IN the_DT sample_NN ,_, and_CC the_DT surprisingly_RB strong_JJ
        association_NN between_IN ADHD_NNP and_CC Obesity_NNP III_NNP ._. Nearly_RB half_NN ,_,
        42_CD ._. 6_CD %_NN ,_, of_IN patients_NNS with_IN Obesity_NNP III_NNP had_VBD ADHD_NNP ,_, that_WDT is_VBZ ,_, the_DT
        OB_NNP +_NN ADHD_NNP population_NN was_VBD concentrated_VBN in_IN the_DT obesity_NN class_NN
        having_VBG the_DT highest_JJS mortality_NN and_CC morbidity_NN risks_NNS ,_, and_CC
        greatest_JJS need_NN for_IN effective_JJ treatment_NN ._.
        Moreover_RB ,_, at_IN all_DT levels_NNS of_IN obesity_NN patients_NNS with_IN ADHD_NNP
        symptoms_NNS were_VBD less_RBR successful_JJ at_IN losing_VBG weight_NN than_IN
        non-_NN ADHD_NNP peers_NNS ._. Compared_VBN to_TO NAD_NNP ,_, AD_NNP had_VBD a_DT significantly_RB
        higher_JJR starting_VBG BMI_NNP (_( 39_CD ._. 6_CD vs_NNS ._. 34_CD ._. 2_LS )_) ,_, yet_RB lost_VBD less_JJR weight_NN
        (_( 2_CD ._. 6_CD vs_NNS ._. 4_CD ._. 0_CD kg_NN /_NN m_NN 2_LS )_) ._. Greater_NNP contrast_NN is_VBZ found_VBN in_IN Obesity_NNP
        III_NNP ,_, with_IN NAD_NNP in_IN that_DT class_NN achieving_VBG more_RBR than_IN twice_RB the_DT
        weight_NN loss_NN of_IN AD_NNP (_( 7_CD ._. 0_CD vs_NNS ._. 2_CD ._. 9_CD kg_NN /_NN m_NN 2_LS )_) ,_, while_IN mean_NN weight_NN
        loss_NN for_IN ADSx_NNP did_VBD not_RB differ_VB significantly_RB from_IN AD_NNP (_( 2_CD ._. 3_LS vs_NNS ._.
        2_CD ._. 6_CD kg_NN /_NN m_NN 2_LS )_) ,_, implying_VBG that_IN the_DT presence_NN of_IN even_RB
        "_'' subthreshhold_NN "_'' ADHD_NNP symptoms_NNS reduces_VBZ the_DT effectiveness_NN of_IN
        obesity_NN treatment_NN ._. In_IN other_JJ words_NNS ,_, in_IN OB_NNP +_NN ADHD_NNP ,_, treatment_NN
        outcome_NN has_VBZ stronger_JJR association_NN with_IN symptoms_NNS of_IN ADHD_NNP than_IN
        level_NN of_IN obesity_NN ._. Effect_NN size_NN of_IN ADHD_NNP for_IN the_DT whole_JJ sample_NN
        was_VBD only_RB about_IN 0_CD ._. 2_CD ,_, but_CC in_IN Obesity_NNP III_NNP patients_NNS ,_, effect_NN
        size_NN was_VBD about_IN 0_CD ._. 5_CD ,_, comparable_JJ ,_, for_IN example_NN ,_, to_TO the_DT
        moderate_JJ effect_NN size_NN of_IN SSRI_NNP drugs_NNS on_IN panic_NN symptoms_NNS [_NN 28_CD ]_NN
        ._.
        Impersistence_NNP was_VBD not_RB the_DT cause_NN of_IN worse_JJR results_NNS for_IN AD_NNP ,_,
        who_WP attended_VBD more_JJR visits_NNS than_IN NAD_NNP (_( 56_CD ._. 0_CD vs_NNS ._. 39_CD ._. 4_LS mean_VB total_JJ
        visits_NNS )_) ,_, over_IN a_DT longer_JJR span_NN of_IN time_NN ._. ADSx_NNP was_VBD no_DT more_RBR
        successful_JJ than_IN AD_NNP ,_, but_CC had_VBD fewer_JJR visits_NNS ,_, comparable_JJ to_TO
        NAD_NNP ,_, in_IN this_DT respect_NN ,_, ADSx_NNP showing_VBG characteristics_NNS
        intermediate_JJ between_IN AD_NNP and_CC NAD_NNP ._. The_DT result_NN is_VBZ AD_NNP ,_, ADSx_NNP and_CC
        NAD_NNP having_VBG similar_JJ rates_NNS of_IN clinic_NN visits_NNS (_( AD_NNP had_VBD 1_CD ._. 5_CD
        visits_NNS /_NN month_NN ,_, ADSx_NNP 1_CD ._. 2_CD and_CC NAD_NNP 1_CD ._. 4_LS )_) ,_, while_IN NAD_NNP had_VBD the_DT
        highest_JJS rate_NN of_IN BMI_NNP decrease_VB (_( NAD_NNP lost_VBD 0_CD ._. 14_CD BMI_NNP /_NN month_NN ,_, ADSx_NNP
        0_CD ._. 075_CD and_CC AD_NNP 0_CD ._. 067_CD )_) ._. However_RB ,_, these_DT statistics_NNS have_VBP limited_JJ
        utility_NN ,_, given_VBN the_DT large_JJ variance_NN in_IN number_NN of_IN visits_NNS and_CC
        months_NNS of_IN treatment_NN ._. The_DT "_'' slow_JJ "_'' aspect_NN of_IN task_NN performance_NN
        in_IN ADHD_NNP has_VBZ been_VBN previously_RB reported_VBN [_NN 29_CD ]_NN ,_, and_CC could_MD be_VB
        described_VBN as_IN a_DT kind_NN of_IN "_'' inefficiency_NN "_'' ,_, that_WDT is_VBZ ,_, taking_VBG more_JJR
        time_NN to_TO accomplish_VB less_JJR ._.
        The_DT reasons_NNS for_IN a_DT strong_JJ association_NN between_IN ADHD_NNP and_CC
        obesity_NN (_( particularly_RB extreme_JJ obesity_NN )_) are_VBP unknown_JJ ,_, but_CC
        there_EX are_VBP a_DT number_NN of_IN reported_VBD findings_NNS that_WDT appear_VBP to_TO be_VB
        relevant_JJ and_CC certainly_RB interesting_JJ ._. For_IN one_CD ,_, evidence_NN
        exists_VBZ that_IN variations_NNS of_IN dopamine_NN receptor_NN (_( DR_NNP )_) genes_NNS
        affect_VBP both_DT conditions_NNS ._. In_IN obesity_NN ,_, DRD_NNP 2_CD and_CC DRD_NNP 4_CD [_NN 30_CD 31_CD ]_NN
        genes_NNS ,_, and_CC in_IN ADHD_NNP ,_, the_DT DRD_NNP 4_CD [_NN 32_CD 33_CD ]_NN gene_NN ,_, have_VBP been_VBN
        implicated_VBN in_IN the_DT transmission_NN of_IN ,_, or_CC predisposition_NN to_TO ,_,
        the_DT disorders_NNS ,_, raising_VBG the_DT possibility_NN that_IN similar_JJ ,_,
        overlapping_VBG or_CC shared_VBN DR_NNP functioning_VBG (_( or_CC dysfunction_NN )_) in_IN
        these_DT disorders_NNS is_VBZ related_VBN to_TO their_PRP$ co-co-occurrence_JJ ._.
        DRD_NNP 2_CD and_CC a_DT range_NN of_IN dopamine_NN and_CC other_JJ genes_NNS have_VBP been_VBN
        associated_VBN with_IN a_DT "_'' reward_NN deficiency_NN syndrome_NN "_'' [_NN 34_CD ]_NN in_IN
        which_WDT insufficient_JJ dopamine-mediated_JJ "_'' natural_JJ "_'' reward_NN leads_VBZ
        to_TO use_NN of_IN "_'' unnatural_NN "_'' rewards_NNS ,_, such_JJ as_IN substances_NNS ,_,
        gambling_NN ,_, risk_NN taking_NN and_CC inappropriate_JJ eating_NN ._. This_DT
        syndrome_NN is_VBZ associated_VBN with_IN obesity_NN [_NN 34_CD ]_NN ,_, and_CC common_JJ in_IN
        ADHD_NNP [_NN 22_CD ]_NN ._. The_DT DRD_NNP 4_CD gene_NN has_VBZ been_VBN associated_VBN with_IN
        "_'' novelty_NN seeking_VBG "_'' traits_NNS ,_, said_VBD to_TO be_VB greater_JJR in_IN substance_NN
        abusers_NNS [_NN 30_CD ]_NN ,_, and_CC individuals_NNS with_IN both_DT DRD_NNP 2_CD and_CC DRD_NNP 4_CD
        genetic_JJ variations_NNS may_MD be_VB especially_RB prone_JJ to_TO multiple_JJ
        difficulties_NNS (_( e_SYM ._. g_SYM ._. ,_, having_VBG both_DT ADHD_NNP and_CC "_'' reward_NN deficiency_NN
        syndrome_NN "_'' )_) [_NN 30_CD ]_NN ,_, further_JJ suggesting_VBG obesity_NN and_CC ADHD_NNP
        could_MD share_VB neurobiological_JJ attributes_NNS ._.
        A_DT recent_JJ study_NN showed_VBD the_DT availability_NN of_IN striatal_NN DRD_NNP 2_CD
        receptors_NNS was_VBD decreased_VBN as_IN a_DT function_NN of_IN increasing_VBG BMI_NNP [_NN
        35_CD ]_NN ,_, supporting_VBG the_DT idea_NN that_IN reward-seeking_JJ behavior_NN
        plays_VBZ a_DT role_NN in_IN the_DT onset_NN or_CC continuation_NN of_IN obesity_NN ._. In_IN
        other_JJ studies_NNS ,_, administration_NN of_IN D_NNP 2_CD agonists_NNS resulted_VBD in_IN
        decreases_NNS in_IN hyperinsulinemia_NN associated_VBN with_IN obesity_NN [_NN 36_CD
        ]_NN ,_, and_CC it_PRP is_VBZ known_VBN that_IN the_DT brain_NN is_VBZ richly_RB supplied_VBN with_IN
        insulin_NN receptors_NNS ,_, including_VBG the_DT cortex_NN and_CC striatal_NN areas_NNS
        [_NN 37_CD ]_NN ,_, suggesting_VBG an_DT intriguing_JJ link_NN between_IN insulin_NN
        resistance_NN ,_, characteristic_NN of_IN obesity_NN ,_, and_CC
        dopamine-mediated_JJ psychiatric_JJ symptoms_NNS ,_, including_VBG ADHD_NNP ._. No_DT
        doubt_NN ,_, this_DT hypothesis_NNS and_CC many_JJ far_RB more_RBR refined_JJ hypotheses_NNS
        will_MD be_VB studied_VBN in_IN coming_VBG years_NNS and_CC will_MD elucidate_NN the_DT
        complex_JJ neurophysiological_JJ connections_NNS hinted_VBD at_IN by_IN the_DT
        above_JJ ._.
        The_DT 27_CD ._. 4_LS %_NN prevalence_NN of_IN ADHD_NNP in_IN obese_NN patients_NNS is_VBZ
        considerably_RB higher_RBR than_IN found_VBD in_IN the_DT general_JJ adult_NN
        population_NN ,_, reported_VBD as_IN 4_CD ._. 7_CD %_NN by_IN Murphy_NNP and_CC Barkley_NNP [_NN 38_CD ]_NN ._.
        Across_IN studies_NNS of_IN other_JJ specific_JJ populations_NNS ,_, prevalence_NN of_IN
        ADHD_NNP or_CC ADHD_NNP symptoms_NNS was_VBD also_RB greater_JJR than_IN in_IN general_JJ ,_, for_IN
        example_NN ,_, cocaine_NN abusers_NNS 12_CD %_NN [_NN 39_CD ]_NN ,_, anxiety_NN disorders_NNS 16_CD %_NN
        [_NN 40_CD ]_NN ,_, panic_NN disorder_NN 22_CD %_NN [_NN 41_CD ]_NN ,_, and_CC substance_NN abusers_NNS
        25_CD %_NN [_NN 42_CD ]_NN ._. Considering_VBG the_DT differing_VBG methods_NNS and_CC
        populations_NNS ,_, the_DT reported_VBD prevalences_NNS are_VBP difficult_JJ to_TO
        compare_VB ,_, yet_RB are_VBP fairly_RB consistent_JJ with_IN one_CD another_DT for_IN the_DT
        most_JJS part_NN ._. The_DT prevalence_NN of_IN OB_NNP +_NN ADHD_NNP in_IN this_DT report_NN is_VBZ
        plausibly_RB within_IN the_DT range_NN of_IN these_DT studies_NNS ._.
        The_DT uniformity_NN of_IN the_DT Inattentive_NNP subtype_NN of_IN ADHD_NNP in_IN
        this_DT adult_NN population_NN was_VBD not_RB unusual_JJ or_CC unexpected_JJ ,_,
        considering_VBG the_DT well-known_JJ attenuation_NN of_IN hyperactive_JJ and_CC
        impulsive_JJ symptoms_NNS observed_VBD as_IN children_NNS with_IN ADHD_NNP grow_VB into_IN
        adolescence_NN and_CC adulthood_NN ,_, compared_VBN to_TO the_DT much_RB stronger_JJR
        retention_NN of_IN inattentive_JJ symptoms_NNS [_NN 14_CD ]_NN ._. This_DT is_VBZ not_RB to_TO
        say_VB that_IN ADHD_NNP adults_NNS do_VBP n't_RB behave_VB impulsively_RB ,_, simply_RB that_IN
        with_IN maturation_NN ,_, continuing_VBG hyperactive_JJ /_NN impulsive_JJ (_( H_NNP /_NN I_PRP )_)
        behaviors_NNS are_VBP usually_RB expressed_VBN in_IN less_RBR obvious_JJ ways_NNS than_IN
        among_IN their_PRP$ school-age_JJ counterparts_NNS ._. That_DT is_VBZ ,_, while_IN ADHD_NNP
        adults_NNS frequently_RB have_VBP impairing_VBG H_NNP /_NN I_PRP 
        symptoms_NNS ,_, the_DT number_NN and_CC types_NNS of_IN
        these_DT behaviors_NNS seldom_RB meet_VBP DSM-IV_NNP diagnostic_JJ 
        criteria_NNS for_IN the_DT H_NNP /_NN I_PRP or_CC Combined_VBN
        subtype_NN of_IN ADHD_NNP ._. DSM-IV_NNP ADHD_NNP subtyping_VBG ,_, strictly_RB applied_VBN ,_,
        is_VBZ likely_JJ to_TO have_VB limited_JJ correlation_NN to_TO neurobiological_JJ
        processes_VBZ (_( assuming_VBG processes_VBZ reflect_VB impulsivity_NN or_CC
        disinhibition_NN )_) ,_, since_IN the_DT level_NN of_IN symptomatic_JJ behavior_NN
        required_VBN for_IN diagnosing_VBG DSM-IV_NNP H_NNP /_NN I_PRP or_CC Combined_VBN subtypes_NNS is_VBZ
        higher_RBR than_IN nearly_RB all_DT ADHD_NNP adults_NNS will_MD display_VB ,_, even_RB if_IN
        substantial_JJ H_NNP /_NN I_PRP behavior_NN is_VBZ evident_JJ ._.
        Another_DT factor_NN is_VBZ that_IN girls_NNS ,_, compared_VBN to_TO boys_NNS ,_, have_VBP
        lower_JJR rates_NNS of_IN H_NNP /_NN I_PRP symptoms_NNS ,_, which_WDT is_VBZ associated_VBN with_IN lower_JJR
        likelihood_NN of_IN being_VBG diagnosed_VBN in_IN childhood_NN ,_, but_CC if_IN
        diagnosed_VBN ,_, girls_NNS more_RBR frequently_RB have_VBP the_DT Inattentive_NNP
        subtype_NN [_NN 12_CD ]_NN ._. It_PRP would_MD be_VB expected_VBN that_IN this_DT difference_NN
        would_MD persist_VB into_IN adulthood_NN ,_, augmenting_VBG the_DT likelihood_NN
        that_IN Inattentive_NNP symptoms_NNS would_MD predominate_NN the_DT clinical_JJ
        presentation_NN ._. In_IN a_DT sample_NN in_IN which_WDT most_JJS patients_NNS are_VBP female_JJ
        and_CC middle-aged_JJ ,_, predominance_NN of_IN the_DT Inattentive_NNP subtype_NN is_VBZ
        predictable_JJ ._.
        Inevitably_RB ,_, there_EX are_VBP numerous_JJ caveats_NNS and_CC limitations_NNS
        that_WDT apply_VBP to_TO this_DT preliminary_JJ work_NN ._. For_IN one_CD ,_, results_NNS
        reflect_VBP the_DT origin_NN of_IN data_NNS in_IN clinical_JJ practice_NN -_: hardly_RB
        ideal_JJ from_IN a_DT research_NN perspective_NN ._. Treatment_NNP settings_NNS may_MD
        favor_VB a_DT higher_JJR case-finding_JJ rate_NN because_IN of_IN the_DT opportunity_NN
        to_TO observe_VB and_CC assess_VB behavior_NN is_VBZ greater_JJR than_IN the_DT methods_NNS
        of_IN prospective_JJ research_NN designs_NNS ._. For_IN example_NN ,_, ADHD_NNP research_NN
        instruments_NNS have_VBP a_DT sensitivity_NN of_IN 70_CD -_: 90_CD %_NN [_NN 43_CD 44_CD ]_NN ,_, and_CC
        would_MD likely_RB identify_VB fewer_JJR cases_NNS of_IN ADHD_NNP than_IN the_DT "_'' gold_NN
        standard_JJ "_'' of_IN careful_JJ clinical_JJ assessment_NN ,_, expected_VBN to_TO find_VB
        most_JJS cases_NNS ._. For_IN this_DT report_NN ,_, diagnosis_NN had_VBD been_VBN made_VBN
        primarily_RB by_IN one_CD interviewer_NN ,_, which_WDT could_MD favor_VB
        consistency_NN ,_, but_CC also_RB leads_VBZ to_TO potential_JJ biases_NNS that_WDT skew_NN
        results_NNS ._. In_IN addition_NN ,_, the_DT modification_NN of_IN age_NN of_IN onset_NN
        criterion_NN for_IN ADHD_NNP may_MD increase_VB difficulty_NN of_IN comparing_VBG
        present_JJ results_NNS to_TO those_DT of_IN studies_NNS using_VBG the_DT unmodified_JJ
        criterion_NN ._. Clearly_RB ,_, for_IN the_DT purpose_NN of_IN comparing_VBG prevalence_NN
        among_IN diverse_JJ populations_NNS ,_, a_DT prospective_JJ design_NN is_VBZ strongly_RB
        advantageous_JJ ,_, but_CC likely_JJ not_RB congruent_NN with_IN the_DT goals_NNS of_IN
        clinical_JJ practice_NN ._.
        Bias_NNP could_MD also_RB be_VB introduced_VBN by_IN patient_NN factors_NNS ,_, such_JJ
        as_IN comorbid_NN conditions_NNS producing_VBG symptoms_NNS which_WDT might_MD not_RB
        be_VB easily_RB separable_JJ from_IN those_DT found_VBN in_IN ADHD_NNP ,_, and_CC
        erroneously_RB diagnosed_VBN as_IN ADHD_NNP ._. Several_JJ disorders_NNS common_JJ in_IN
        obese_NN patients_NNS fit_VBP into_IN this_DT category_NN ,_, e_SYM ._. g_SYM ._. ,_, obstructive_JJ
        sleep_NN apnea_NN ,_, depression_NN ,_, and_CC anxiety_NN disorders_NNS ._. While_IN the_DT
        differential_NN characteristics_NNS of_IN these_DT conditions_NNS ,_, e_SYM ._. g_SYM ._. ,_,
        relative_JJ duration_NN ,_, pervasiveness_NNS and_CC continuity_NN of_IN symptoms_NNS
        can_MD help_VB distinguish_VB one_CD from_IN another_DT ,_, the_DT nature_NN and_CC
        interactions_NNS of_IN these_DT comorbidities_NNS are_VBP not_RB particularly_RB
        well-delineated_JJ ._. While_IN careful_JJ clinical_JJ practice_NN requires_VBZ
        effort_NN to_TO avoid_VB diagnosing_VBG ADHD_NNP if_IN symptoms_NNS are_VBP not_RB
        sufficiently_RB distinct_JJ from_IN those_DT of_IN confounding_VBG disorders_NNS ,_,
        reducing_VBG error_NN requires_VBZ further_JJ research_NN into_IN the_DT effects_NNS
        of_IN comorbidities_NNS intercurrent_NN with_IN ADHD_NNP ._.
        Another_DT form_NN of_IN bias_NN originates_VBZ in_IN patients_NNS '_POS
        predisposition_NN to_TO endorse_VB symptoms_NNS because_IN of_IN dysphoria_NN ,_,
        negative_JJ affectivity_NN ,_, or_CC readiness_NN to_TO attribute_VB distress_NN to_TO
        some_DT preferred_JJ ,_, rather_RB than_IN actual_JJ ,_, source_NN when_WRB queried_VBN by_IN
        the_DT interviewer_NN ._. For_IN the_DT OB_NNP +_NN ADHD_NNP population_NN ,_, the_DT idea_NN is_VBZ
        that_IN some_DT patients_NNS may_MD have_VB had_VBD a_DT preference_NN for_IN endorsing_VBG
        ADHD_NNP symptoms_NNS ,_, instead_RB of_IN accepting_VBG more_RBR accurate_JJ
        explanations_NNS for_IN distress_NN or_CC lack_NN of_IN obesity_NN treatment_NN
        progress_NN ,_, e_SYM ._. g_SYM ._. ,_, failure_NN to_TO lose_VB weight_NN while_IN being_VBG
        unwilling_JJ to_TO exercise_VB ._. (_( "_'' I_PRP ca_MD n't_RB lose_VB weight_NN because_IN I_PRP just_RB
        get_VBP so_RB distracted_VBN ._. "_'' )_)
        Some_DT forms_NNS of_IN endorsement_NN bias_NN are_VBP readily_RB seen_VBN in_IN
        medical_JJ practice_NN ,_, for_IN example_NN ,_, patients_NNS who_WP would_MD rather_RB
        talk_VB about_IN somatic_JJ events_NNS than_IN discuss_VB their_PRP$ anxieties_NNS or_CC
        depressed_VBN mood_NN ._. Implications_NNP for_IN the_DT OB_NNP +_NN ADHD_NNP population_NN are_VBP
        hard_JJ to_TO assess_VB ,_, since_IN this_DT form_NN of_IN bias_NN and_CC its_PRP$ effects_NNS on_IN
        research_NN of_IN ADHD_NNP prevalence_NN have_VBP not_RB received_VBN comparable_JJ
        study_NN ,_, nor_CC are_VBP there_RB reports_NNS of_IN the_DT frequency_NN of_IN
        encountering_VBG this_DT bias_NN in_IN clinical_JJ work_NN with_IN adult_NN ADHD_NNP
        patients_NNS ._. Moreover_RB ,_, no_DT special_JJ measures_NNS were_VBD taken_VBN to_TO
        reduce_VB or_CC account_VB for_IN such_JJ biases_NNS during_IN the_DT course_NN of_IN
        diagnosing_VBG patients_NNS in_IN the_DT present_JJ sample_NN ,_, rendering_VBG it_PRP
        quite_RB difficult_JJ to_TO estimate_VB how_WRB much_JJ and_CC what_WP kind_NN of_IN
        effect_NN biases_NNS have_VBP had_VBN on_IN the_DT above_JJ reported_VBD prevalences_NNS of_IN
        OB_NNP +_NN ADHD_NNP ._. At_IN this_DT point_NN ,_, it_PRP remains_VBZ an_DT open_JJ question_NN ,_,
        suggesting_VBG additional_JJ reasons_NNS for_IN cautious_JJ interpretation_NN
        of_IN the_DT results_NNS given_VBN in_IN this_DT report_NN ._.
        The_DT demographic_JJ characteristics_NNS of_IN the_DT sample_NN population_NN
        are_VBP worth_JJ a_DT few_JJ comments_NNS ._. Notably_RB ,_, about_IN 90_CD %_NN of_IN the_DT
        patients_NNS were_VBD women_NNS ,_, which_WDT obviously_RB does_VBZ not_RB reflect_VB the_DT
        general_JJ population_NN ,_, but_CC may_MD not_RB be_VB surprising_VBG in_IN this_DT
        context_NN because_IN more_JJR women_NNS than_IN men_NNS are_VBP concerned_VBN about_IN
        weight_NN gain_NN ,_, and_CC are_VBP more_RBR likely_JJ to_TO seek_VB medical_JJ care_NN than_IN
        male_JJ contemporaries_NNS ._. The_DT patients_NNS as_IN a_DT group_NN were_VBD also_RB
        distinctly_RB middle-aged_JJ ,_, no_DT doubt_NN reflecting_VBG the_DT fact_NN that_IN
        older_JJR individuals_NNS are_VBP more_RBR likely_JJ to_TO be_VB able_JJ to_TO afford_VB
        non-insured_JJ medical_JJ care_NN (_( obesity_NN treatment_NN is_VBZ n't_RB covered_VBN
        under_IN most_JJS policies_NNS )_) ,_, and_CC the_DT time_NN to_TO devote_VB to_TO their_PRP$ own_JJ
        needs_NNS ._.
        Some_DT effects_NNS of_IN demographic_JJ factors_NNS on_IN diagnosis_NN of_IN ADHD_NNP
        were_VBD discussed_VBN above_IN ._. Gender_NNP and_CC age_NN differences_NNS (_( e_SYM ._. g_SYM ._. ,_,
        younger_JJR patients_NNS or_CC higher_JJR male_JJ to_TO female_JJ ratio_NN )_) could_MD
        conceivably_RB affect_VB the_DT range_NN and_CC intesity_NN of_IN ADHD_NNP symptoms_NNS
        that_WDT are_VBP observed_VBN ,_, prevalence_NN findings_NNS ,_, and_CC individual_JJ as_IN
        well_RB as_IN aggregate_JJ response_NN to_TO obesity_NN treatment_NN ._.
        In_IN addition_NN ,_, generalizability_NN of_IN conclusions_NNS based_VBN on_IN
        the_DT data_NNS in_IN this_DT report_NN are_VBP limited_VBN by_IN a_DT modest_JJ sample_NN
        size_NN ,_, and_CC uncertainty_NN that_IN the_DT bariatric_JJ patients_NNS in_IN the_DT
        sample_NN were_VBD truly_RB representative_NN of_IN the_DT general_JJ obese_NN
        population_NN ._. Results_NNS could_MD be_VB misleading_JJ ,_, for_IN example_NN ,_, if_IN
        the_DT sample_NN had_VBD a_DT disproportion_NN of_IN individuals_NNS with_IN serious_JJ
        medical_JJ or_CC psychiatric_JJ problems_NNS ,_, higher_JJR weight_NN or_CC greater_JJR
        social_JJ skill_NN deficits_NNS ,_, even_RB if_IN the_DT sample_NN is_VBZ construed_VBN to_TO
        be_VB typical_JJ of_IN those_DT seen_VBN in_IN similar_JJ practices_NNS ._.
      
      
        Conclusion_NNP
        This_DT report_NN is_VBZ explicitly_RB exploratory_JJ ,_, and_CC its_PRP$ findings_NNS
        need_VBP to_TO be_VB replicated_VBN in_IN larger_JJR and_CC more_RBR systematic_JJ
        studies_NNS ._. Nonetheless_RB ,_, these_DT findings_NNS are_VBP already_RB quite_RB
        interesting_JJ and_CC could_MD have_VB implications_NNS for_IN the_DT
        understanding_NN of_IN the_DT etiology_NN of_IN obesity_NN as_RB well_RB as_IN the_DT
        treatment_NN of_IN obesity_NN ._. The_DT nature_NN of_IN the_DT connections_NNS ,_, to_TO the_DT
        extent_NN that_IN they_PRP exist_VBP ,_, between_IN attention_NN and_CC obesity_NN is_VBZ of_IN
        course_NN not_RB at_IN all_DT clear_JJ ,_, but_CC the_DT results_NNS may_MD point_VB to_TO forms_NNS
        of_IN attentional_NN components_NNS and_CC impulsivity_NN playing_VBG a_DT role_NN in_IN
        the_DT onset_NN or_CC continuation_NN of_IN obesity_NN ,_, or_CC that_IN attentional_NN
        mechanisms_NNS are_VBP linked_VBN in_IN some_DT way_NN to_TO metabolic_JJ and_CC energy_NN
        storage_NN regulation_NN ._.
        Implications_NNP for_IN clinical_JJ practice_NN may_MD be_VB of_IN more_RBR
        immediate_JJ consequence_NN ._. Treatment_NNP of_IN obesity_NN has_VBZ been_VBN
        marginally_RB effective_JJ at_IN best_JJS ,_, particularly_RB for_IN extreme_JJ
        obesity_NN ._. If_IN an_DT attentional_NN disorder_NN is_VBZ present_JJ ,_, conceivably_RB
        its_PRP$ treatment_NN could_MD improve_VB obesity_NN treatment_NN outcome_NN ,_,
        which_WDT makes_VBZ awareness_NN of_IN the_DT ADHD-obesity_NNP comorbidity_NN
        pragmatically_RB important_JJ ._. It_PRP has_VBZ been_VBN shown_VBN that_DT reduction_NN
        of_IN body_NN weight_NN as_RB small_JJ as_IN 5_CD %_NN substantially_RB reduces_VBZ the_DT
        morbidity_NN and_CC mortality_NN risks_NNS of_IN obesity_NN ,_, so_RB even_RB if_IN
        recognizing_VBG and_CC treating_VBG ADHD_NNP is_VBZ only_RB a_DT modest_JJ contributor_NN
        to_TO reducing_VBG body_NN fat_JJ mass_NN ,_, it_PRP is_VBZ worthwhile_JJ on_IN that_DT grounds_NNS
        alone_RB ._. Moreover_RB ,_, the_DT impairment_NN of_IN ADHD_NNP is_VBZ an_DT intrinsic_JJ
        reason_NN to_TO diagnose_NN and_CC treat_VB the_DT condition_NN ,_, because_IN even_RB if_IN
        comorbid_NN obesity_NN were_VBD not_RB changed_JJ ,_, normalizing_VBG brain_NN
        function_NN in_IN ADHD_NNP sufferers_NNS more_RBR often_RB than_IN not_RB provides_VBZ
        substantial_JJ benefit_NN and_CC improved_VBN quality_NN of_IN life_NN ._.
        The_DT apparent_JJ association_NN of_IN OB_NNP +_NN ADHD_NNP ,_, relatively_RB poor_JJ
        obesity_NN treatment_NN outcome_NN and_CC high_JJ prevalence_NN of_IN OB_NNP +_NN ADHD_NNP
        (_( 27_CD ._. 4_LS %_NN )_) ,_, especially_RB in_IN the_DT extremely_RB obese_NN (_( 42_CD ._. 6_CD %_NN )_) ,_, argue_VBP
        that_DT comorbid_NN ADHD_NNP increases_VBZ the_DT health_NN risks_NNS of_IN obesity_NN ,_,
        and_CC that_IN extreme_JJ obesity_NN ,_, itself_PRP a_DT stressful_JJ condition_NN ,_,
        adds_VBZ burden_NN to_TO the_DT profound_JJ impairments_NNS common_JJ in_IN ADHD_NNP ._. The_DT
        chance_NN that_IN more_JJR knowledge_NN could_MD lead_VB to_TO reduction_NN of_IN
        suffering_VBG ,_, disability_NN and_CC economic_JJ cost_NN offers_VBZ compelling_JJ
        reasons_NNS for_IN further_JJ investigation_NN of_IN this_DT subject_NN ._.
        Inclusion_NNP of_IN more_RBR diverse_JJ and_CC non-clinical_JJ populations_NNS of_IN
        obese_NN and_CC extremely_RB obese_NN individuals_NNS ,_, and_CC using_VBG research_NN
        designs_NNS that_IN better_JJR account_NN for_IN rater_NN and_CC subject_JJ biases_NNS ,_,
        inter-rater_JJ reliability_NN ,_, and_CC diagnostic_JJ methodology_NN ,_, will_MD
        likely_RB give_VB more_RBR definitive_JJ answers_NNS to_TO this_DT report_NN 's_POS
        questions_NNS and_CC implications_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        The_DT author_NN (_( 1_LS )_) JRA_NNP developed_VBD and_CC wrote_VBD this_DT report_NN ._.
      
    
  
